Psychedelics are Bringing a new wind to the Pharmacopoeia
Neuroscience and Neurological Surgery February 27, 2025 Michel Bourin
Hundreds of clinical trials worldwide are testing hallucinogenic substances—psilocybin, LSD, DMT, mescaline, MDMA, and ketamine—for their ability to restore mental health. Psilocybin is the active ingredient in hallucinogenic mushrooms, LSD derives from ergot compounds, DMT is part of ayahuasca, mescaline comes from peyote, and MDMA is an amphetamine known as ecstasy.